Dr Escudier explained that the biomarkers identify patients who will respond to this targeted agent — music to the manufacturers’ ears, I’m sure! It is interesting in the context of individualising therapy, and raises questions which are...
Robert Dreicer MD describes this negative finding which was nevertheless a fine study, indicating the value of large phase III investigations. Orteronel is similar in action to abiraterone, and there were responses: in the non-USA patients these...
SAN FRANCISCO: Heather Cheng was very much in favour of using enzalutamide after abiraterone since her data show a 30 per cent response rate even in a third of patients who had not responded at all to abi, and higher proportions in both abi...
SAN FRANCISCO—Dr Tomasz Beer, said their new data make a good case for using enzalutamide to treat prostate cancer in chemo-naïve patients. He spoke reassuringly about both efficacy and safety. Tomasz Beer MD, Oregon Health & Science...
For osteoporosis a new molecular drug that activates bone formation without bone resorption has been reported in the New England Journal of Medicine. Treatment with romosozumab in post menopausal women with low bone mineral density was compared with...
A report just published in the Journal of the American Medical Association, JAMA note that although the role of vitamin E has for treating moderately severe Alzheimer’s Disease had been esetablished, it’s efficacy had not been properly...
The British Medical Journal reports that dietary fibre can prevent heart disease. Multiple studies have already found an association between fibre and cardiovascular disease, but there are many different types of dietary fibre, and not all studies...
The ‘Mediterranean diet’ — rich in fish, whole grains, fruit, and vegetables, and including moderate amounts of red wine — is widely believed to protect against a number of diseases. A new study has now tried settle the issue once and...
A New Year article in JAMA Ophthalmology points out that smoking cessation can halve your risk of needing a cataract extraction later in life. The researchers looked at 40 000 Swedish men between the ages of 45 and 79 years and found there was a...
CHICAGO—The present-day standard CHOP-rituximab regimen for all indolent lymphomas has been overturned according to German investigators reporting here to the annual meeting of the American Society of Clinical Oncology. Professor Mathias Rummel of...
AudioMedica News Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / Subscribe RSS Feed Robert Pirker ROBERT PIRKER , Medical...
AudioMedica News Lung Cancer Screening: Wait for Prospective Study Findings! Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / Subscribe RSS Feed Ugo Pastorino UGO PASTORINO , Istituto Nazionale...



